background
cutan
leishmaniasi
tropic
diseas
affect
one
million
patient
annual
leishmania
l
mexicana
one
major
etiolog
agent
america
establish
first
experiment
infect
l
l
mexicana
canid
method
beagl
dog
infect
intraderm
culturederiv
l
l
mexicana
follow
skin
ulcer
develop
histopatholog
sign
parasit
burden
immun
statu
infect
dog
result
infect
dog
develop
uniform
ovalcraterform
ulcer
similar
observ
human
associ
mix
helper
helper
immun
respons
parasit
detect
heal
lesion
week
postinfect
higher
antileishmania
igg
level
correl
larger
lesion
high
ratio
associ
level
splenomegali
conclus
canin
model
describ
work
use
understand
l
l
mexicana
immunopathogenensi
drug
vaccin
develop
leishmanias
group
parasit
diseas
affect
million
peopl
annual
cutan
chiclero
ulcer
mucocutan
viscer
leishmaniasi
kalaazar
differ
clinic
form
diseas
caus
parasit
two
subgenu
leishmania
leishmania
leishmania
viannia
parasit
transmit
sand
fli
phlebotomu
lutzomyia
genu
old
new
world
respect
cutan
leishmaniasi
cl
rank
ninth
infecti
neglectedtrop
diseas
estim
burden
million
new
case
per
year
dali
disabilityadjust
life
year
l
l
mexicana
one
major
speci
respons
cl
america
found
argentina
brazil
costa
rica
guatemala
far
north
mexico
mexico
ministri
health
report
incid
case
annual
although
diseas
like
underreport
drug
treatment
infect
patient
complic
drug
avail
limit
efficaci
vaccin
still
earli
experiment
stage
dog
believ
play
import
role
domest
reservoir
leishmania
parasit
demonstr
l
l
chagasi
due
rel
high
natur
infect
rate
mani
region
rang
lifelong
persist
parasit
particularli
skin
without
clinic
sign
diseas
drug
treatment
infect
dog
recommend
prevent
emerg
drug
resist
parasit
consequ
countri
brazil
recommend
cull
infect
dog
prevent
spread
diseas
although
efficaci
measur
critic
import
prioriti
thu
develop
veterinari
vaccin
requir
appropri
anim
model
evalu
rodent
model
extens
use
studi
leishmania
infect
includ
inbr
outbr
mous
strain
hamster
provid
key
inform
immunopatholog
diseas
howev
studi
dog
also
warrant
understand
role
leishmania
transmiss
test
drug
vaccin
efficaci
studi
canin
leishmaniasi
focus
viscer
form
caus
l
l
chagasi
l
l
infantum
base
observ
natur
experiment
infect
anim
unexpectedli
canin
cutan
leishmaniasi
littl
studi
domest
dog
poorli
describ
high
preval
infect
l
v
braziliensi
l
v
guayanensi
l
l
panamensi
report
dog
colombia
mexico
case
canin
leishmaniasi
report
possibl
caus
l
l
infantum
although
parasit
speci
determin
case
natur
infect
l
l
mexicana
also
describ
dog
natur
infect
l
v
braziliensi
found
present
thrombocytopenia
anemia
skin
lesion
parasit
could
observ
lesion
also
present
diffus
chronic
inflamm
dermi
fibrinoid
degener
less
frequent
vascul
howev
experiment
model
canin
cutan
leishmaniasi
scarc
experiment
infect
l
v
brasiliensi
found
induc
cutan
lesion
three
four
mongrel
dog
month
infect
lesion
tend
heal
month
histolog
lesion
similar
characterist
observ
natur
infect
anim
addit
studi
need
character
dog
model
studi
develop
canin
model
cutan
leishmaniasi
caus
experiment
infect
l
l
mexicana
parasit
main
speci
circul
southern
mexico
central
america
describ
clinic
parasitolog
immunolog
aspect
experiment
infect
beagl
dog
provid
good
model
futur
test
novel
drug
vaccin
cutan
leishmaniasi
well
studi
immunopathogenensi
canin
host
six
beagl
dog
three
litter
age
two
three
month
use
anim
acclim
threefour
month
anim
facil
temperatur
light
food
control
receiv
treatment
helminth
vaccin
rabi
viru
canin
distemp
viru
type
adenoviru
coronaviru
parainfluenza
parvoviru
leptospira
anim
procedur
perform
accord
nation
intern
guidelin
approv
institut
bioethic
committe
autonom
univers
yucatan
author
number
leishmania
l
mexicana
strain
cultur
media
fetal
bovin
serum
mercaptoethanol
mm
sodium
pyruv
iu
penicillin
mgml
streptomycin
filter
human
urin
gener
anesthesia
ketaminexilazin
mgkg
iv
beagl
dog
receiv
promastigot
resuspend
pb
solut
intraderm
shave
back
beagl
dog
daili
examin
clinic
sign
includ
rectal
temperatur
breath
heart
rate
addit
fece
color
presenc
polydipsia
polyuria
andor
abnorm
excret
observ
skin
lesion
photograph
measur
weekli
use
vernier
calip
period
week
sybr
greenbas
real
timepcr
optim
quantifi
l
l
mexicana
parasit
burden
prescapular
lymph
node
skin
lesion
first
mg
tissu
ground
morter
pestl
dna
obtain
genom
dna
purif
kit
promega
madison
wi
follow
manufactur
instruct
use
primer
target
bp
sequenc
l
l
mexicana
minicircl
forward
primer
revers
primer
reaction
contain
ng
dna
reaction
volum
nm
forward
revers
primer
kappa
sybr
fast
univers
qpcr
mix
reaction
consist
min
activ
follow
cycl
min
high
resolut
melt
curv
analysi
end
reaction
standard
curv
prepar
uninfect
dog
dna
spike
serial
dilut
l
l
mexicana
dna
cover
dynam
rang
parasit
equivalentreact
sampl
standard
run
triplic
standard
deviat
among
triplic
less
cq
dog
euthan
week
postinfect
barbitur
overdos
necropsi
perform
immedi
regist
detail
caviti
organ
fluid
spleen
liver
extract
weight
measur
biopsi
skin
spleen
prescapular
lymph
node
liver
tissu
embed
paraffin
section
stain
hematoxylin
eosin
evalu
lesion
andor
parasit
humor
immun
respons
induc
l
l
mexicana
infect
evalu
measur
level
total
igg
subtyp
parasit
lysat
recombin
antigen
solubl
l
l
mexicana
antigen
sla
prepar
parasit
cultur
describ
previous
follow
day
cultur
medium
life
technolog
carlsbad
ca
briefli
ml
parasit
wash
three
time
phosphat
buffer
solut
pb
ph
sonic
three
ultrasound
cycl
sonic
vibra
cell
newtown
ca
min
w
lyse
suspens
centrifug
g
min
supernat
recollect
store
aliquot
use
recombin
gener
provid
dr
peter
hotez
baylor
colleg
medicin
houston
tx
usa
nineti
sixwel
plate
coat
overnight
solubl
l
l
mexicana
antigen
recombin
protein
block
plasma
sampl
dilut
total
igg
igg
isotyp
respect
incub
h
wash
phosphataseconjug
rabbit
antidog
igg
dilut
sigma
usa
peroxidaseconjug
goat
antidog
sheep
antidog
dilut
serotec
uk
ad
wash
plate
reveal
pnpp
ophenylenediamin
substrat
respect
absorb
measur
biorad
micropl
reader
cytokin
level
quantifi
plasma
well
spleen
liver
extract
supernat
g
fresh
tissu
ground
mortar
pestl
resuspend
ml
medium
sigmaaldrich
inc
st
loui
mo
homogen
centrifug
g
minut
supernat
store
duoset
canin
kit
r
system
inc
minneapoli
use
measur
cytokin
level
tissu
supernant
plasma
sampl
accord
instruct
manufactur
dog
infect
dose
l
l
mexicana
promastigot
via
intraderm
rout
anim
show
local
erythema
nine
day
postinfect
site
inject
week
postinfect
observ
papul
anim
ulcer
expand
form
typic
oval
craterlik
lesion
figur
major
anim
present
lesion
cm
diamet
variat
rang
cm
diamet
activ
skin
ulcer
present
median
week
heal
larg
individu
variat
durat
rang
six
week
figur
lesion
one
male
dog
never
heal
still
activ
week
infect
effect
litter
origin
observ
size
durat
lesion
beagl
belong
one
litter
larger
lesion
beagl
anoth
litter
present
smaller
longlast
lesion
beagl
third
litter
intermedi
size
lesion
daili
rectal
temperatur
measur
show
weekli
increas
dog
pyrexia
also
observ
two
dog
day
postinfect
ulcer
format
reach
respect
infect
anim
euthan
week
postinfect
lesion
heal
except
one
dog
necropsi
carri
detect
gross
abnorm
analyz
tissu
appear
macroscop
normal
spleen
weight
data
normal
bodi
weight
four
six
dog
three
male
one
femal
present
splenomegali
outsid
normal
rang
figur
biopsi
differ
tissu
also
analyz
histopatholog
damag
skin
tissu
heal
lesion
show
focal
inflammatori
cell
infiltr
dermi
around
adipos
tissu
loss
epidermi
integr
figur
prescapular
lymph
node
present
dissemin
atrophi
interstiti
edema
enlarg
cortic
layer
necrot
fibrinoid
zone
also
intens
vascul
tissu
figur
liver
beagl
show
hydrop
lipid
sever
degener
around
central
area
multipl
focu
oncot
necrosi
figur
kidney
sever
case
inflamm
interstiti
nephriti
found
beagl
extens
histiocyt
lymphocyt
infiltr
displac
renal
tubul
figur
inflamm
observ
kidney
infect
anim
howev
parasit
infect
cell
observ
tissu
section
parasit
burden
measur
site
heal
lesion
prescapular
lymph
node
qpcr
target
l
l
mexicana
kdna
parasit
detect
biopsi
infect
anim
similar
parasit
burden
skin
lymph
node
figur
parasit
burden
vari
parasit
equivalentmg
lymph
node
parasit
equivalentmg
heal
lesion
higher
parasit
burden
heal
lesion
tend
associ
increas
splenomegali
although
reach
statist
signific
r
p
associ
found
parasit
burden
lymph
node
immun
respons
infect
dog
analyz
determin
whether
potenti
immun
respons
correl
diseas
progress
measur
serum
antibodi
level
well
cytokin
level
serum
tissu
differ
time
point
antileishmania
total
igg
rapidli
increas
follow
infect
reach
maximum
level
week
postinfect
antibodi
level
maintain
week
postinfect
figur
high
igg
level
significantli
associ
larg
lesion
size
r
p
analysi
antibodi
isotyp
show
gradual
igg
isotyp
switch
cours
infect
predomin
isotyp
four
week
postinfect
predomin
isotyp
week
postinfect
indic
chang
ratio
figur
high
ratio
week
postinfect
significantli
associ
splenomegali
r
p
tend
associ
increas
parasit
burden
lesion
r
p
also
evalu
antibodi
igg
level
reach
maximum
week
postinfect
present
decreas
week
post
infect
figur
cytokin
measur
liver
spleen
tissu
homogen
well
serum
sampl
week
postinfect
elisa
could
detect
spleen
plasma
sampl
detect
liver
sampl
figur
hand
found
sampl
appear
predomin
cytokin
compar
figur
signific
associ
found
cytokin
level
immun
parasitolog
paramet
p
although
higher
level
spleen
liver
tend
associ
lower
antileishmania
igg
well
shorter
durat
smaller
size
skin
lesion
viscer
leishmaniasi
extens
studi
dog
sever
experiment
model
describ
littl
known
canin
cutan
leishmaniasi
present
first
lesion
durat
l
v
braziliensi
model
also
highli
variabl
rang
week
elev
variabl
time
length
made
former
model
limit
practic
use
higher
parasit
dose
also
use
model
canin
viscer
leshmaniasi
led
limit
clinic
sign
clinic
patholog
evolut
l
l
mexicana
describ
studi
also
similar
describ
naturallyoccur
cutan
leishmaniasi
dog
thu
dog
natur
infect
l
v
braziliensi
l
panamensi
present
skin
lesion
vari
size
cm
similarli
histopatholog
damag
observ
skin
tissu
similar
observ
natur
infect
anim
remark
observ
lymphoid
infiltr
kidney
first
report
indic
possibl
renal
damag
experiment
cutan
leishmaniasi
induct
glomerulonephr
infect
l
l
infantum
recent
attribut
deposit
immun
complex
follow
limit
cellular
immun
addit
import
note
l
l
mexicana
caus
rather
wide
spectrum
clinic
diseas
includ
diffus
viscer
form
case
particularli
patient
low
immun
statu
also
similar
natur
infect
appar
absenc
parasit
heal
lesion
assess
microscop
tissu
section
howev
use
techniqu
higher
sensit
qpcr
clearli
demonstr
import
parasit
burden
week
infect
skin
secondari
lymphoid
organ
six
infect
anim
assay
reli
detect
parasit
dna
presenc
live
parasit
highli
like
observ
mani
anim
model
leishmania
infect
import
result
suggest
infect
dog
reach
asymptomat
stage
parasit
persist
indic
one
hand
infect
may
reactiv
upon
alter
immun
statu
hand
remain
potenti
sourc
infect
may
serv
reservoir
parasit
brazil
clearli
establish
domest
dog
main
reservoir
l
chagasi
role
dog
transmiss
leishmania
speci
caus
cutan
form
diseas
well
understood
observ
long
last
ulcer
lesion
high
suscept
infect
dog
argentina
suggest
could
play
import
epidemiolog
role
transmiss
leishmania
parasit
speci
caus
cutan
leishmaniasi
import
implic
definit
epidemiolog
control
measur
inde
massiv
euthanasia
dog
brazil
question
efficaci
reduc
infect
rate
human
consequ
world
health
organ
priorit
develop
veterinari
vaccin
therefor
model
canin
cutan
leishmaniasi
may
help
evalu
vaccin
candid
nonetheless
develop
anim
model
may
includ
evalu
addit
sand
fli
saliva
andor
infect
sand
fli
bite
shown
dramat
alter
host
immun
respons
leishmania
infect
mice
even
though
effect
dog
less
straightforward
analysi
immun
respons
l
l
mexicana
infect
dog
indic
increas
antiparasit
igg
igg
level
eight
week
postinfect
seem
much
faster
observ
infect
l
l
chagasiinfantum
case
antibodi
level
took
year
increas
howev
igg
level
appear
rise
faster
intraderm
infect
use
nonetheless
similar
viscer
form
diseas
higher
igg
level
associ
symptomat
diseas
found
stronger
humor
respons
associ
larger
lesion
size
interestingli
analysi
igg
isotyp
reveal
gradual
shift
predomin
predomin
isotyp
cours
infect
suggest
initi
type
immun
respons
begin
infect
follow
progress
type
respons
later
stage
chang
immun
profil
would
explain
initi
control
lesion
lead
heal
well
failur
immun
system
achiev
parasit
elimin
allow
detect
leishmania
parasit
dna
heal
lesion
lymph
node
also
agreement
pathogen
role
report
l
l
mexicana
infect
murin
model
howev
cytokin
measur
show
signific
product
plasma
liver
spleen
detect
liver
rather
mix
respons
thu
like
occur
report
canin
viscer
leishmaniasi
clear
immun
polar
difficult
observ
nonetheless
immun
respons
character
predomin
antibodi
higher
product
seem
rather
associ
parasit
control
evidenc
signific
associ
reduc
splenomegali
tendenc
lead
decreas
lesion
size
durat
agreement
establish
mous
model
well
observ
canin
viscer
leishmaniasi
analysi
addit
cytokin
tissu
drain
lymph
node
help
character
immun
respons
anim
model
present
first
model
canin
cutan
leishmaniasi
caus
l
l
mexicana
reproduc
model
present
typic
ulcer
skin
lesion
anim
characterist
similar
observ
natur
infect
anim
parasitolog
analysi
clearli
show
longterm
persist
parasit
heal
skin
lesion
lymph
node
also
infect
associ
mix
respons
although
profil
seem
associ
better
parasit
control
model
use
clarifi
role
dog
reservoir
l
l
mexicana
transmiss
cycl
studi
also
provid
new
insight
immunopathogenesi
canin
cutan
leishmaniasi
final
model
use
evalu
novel
vaccin
drug
candid
